SightfileU.S. market data from official filings

ENSYSCE BIOSCIENCES INC (ENSC)

Name: ENSYSCE BIOSCIENCES INC (ENSC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001716947 · EDGAR filings · Updated 2026-07-15

ENSYSCE BIOSCIENCES INC (ENSC) has reported institutional ownership of 5.2%, with 15 institutional managers holding positions valued at $261.5K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

5.2%

Institutional managers

Reported 13F value

$261.5K

Data flags

3 active

from SEC filings

Latest updates

2026-07-15 — Current report (8-K) filed
2026-06-26 — EFFECT filed
2026-06-04 — Shelf registration (S-3) filed
2026-05-22 — Current report (8-K) filed
2026-05-15 — Quarterly report (10-Q) filed
2026-05-15 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENSYSCE BIOSCIENCES INC has 15 institutional holders and institutional ownership of 5.2%.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-05-22 (recurring since 2020-11-30) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2020-05-07) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-05-14 (recurring since 2021-05-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

NEUROSENSE THERAPEUTICS LTD (NRSN) · Tenon Medical Inc (TNON) · TransCode Therapeutics Inc (RNAZ) · LIMINATUS PHARMA INC. (LIMN) · CYCLERION THERAPEUTICS INC COM (CYCN) · Aptevo Therapeutics Inc (APVO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.